SHOULDER INNOVATIONS, INC.

SI ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024
Operating Activities
Net Income $-40.4M $-15.6M
Depreciation & Amortization
Depreciation $2.9M $1.9M
Amortization
Stock-Based Compensation $996.0K $754.0K
Net Cash from Operating Activities $-28.6M $-14.1M
Investing Activities
Capital Expenditures $7.4M $4.0M
Business Acquisitions
Net Cash from Investing Activities $-95.6M $14.0M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $145.0M $66.0K
Net Change in Cash
Free Cash Flow $-36.0M $-18.2M